| Aug 22 |
Cardiol Therapeutics: First-Mover In CBD-Based Treatment For Heart Disease
|
| Jul 12 |
We're Keeping An Eye On Cardiol Therapeutics' (TSE:CRDL) Cash Burn Rate
|
| Jun 27 |
Cardiol Therapeutics Reports Results of 2024 Annual General and Special Meeting of Shareholders
|
| Jun 25 |
Cardiol Therapeutics to Webcast Virtual Annual General and Special Meeting of Shareholders on June 26th at 4:30 p.m. EDT
|
| Jun 17 |
Hope on the Horizon: Results from MAvERIC-Pilot Show Heartfelt Progress for Patients
|
| Jun 13 |
Cardiol slips after mid-stage data for heart disease therapy
|
| Jun 13 |
Cardiol Therapeutics Announces Positive Topline Data from its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis
|
